This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation CAR & T Cell Therapies
February 27 - March 3, 2023 | Part of BPI West
San Diego Convention CenterSan Diego, CA

Shon Green
Senior Director, Translational R&D at Umoja Biopharma, USA


Dr. Green has focused her career on developing engineered T cell therapies and employing novel engineering approaches to improve solid tumor targeting. Now at Umoja Biopharma, she is leading the translational R&D strategy to obtain proof-of-concept and assess the safety of in vivo engineered CAR-T cell products for cancer immunotherapy.

Agenda Sessions

  • Conference Opening and Welcome

  • Panel: Gene Editing Tools to Produce Smart CART Cells